Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Japanese investigators study antinociceptive dynorphin analogue

Aug. 10, 1998

Promising new antipsychotic agent in active development at Gedeon Richter

Aug. 10, 1998

Exelon demonstrates robust effects on cognitive function in Alzheimer's disease patients

Aug. 10, 1998

Clinical trials to begin shortly with KT-7515/CEP-1347

July 31, 1998

Schizophrenia collaboration between Neurogen and Schering-Plough ends successfully

July 31, 1998

Investigation at Sumitomo leads to new psychotropic agents

July 31, 1998

NMDA subtype-selective blockers prepared and evaluated at Roche

July 31, 1998

Zopiclone improves sleep in rheumatoid arthritis patients

July 31, 1998

Wyeth-Ayerst and Scios terminate North American trial of Fiblast and continue European trial

July 30, 1998

Mechanism of action, anxiolytic and anticonvulsant activity of AWD-131-138

July 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...